Last edition
News about " pan-Canadian Pharmaceutical Alliance"
Roche Canada Completes pCPA Negotiations for Perjeta in Early HER2-Positive Breast Cancer
Roche Canada has completed pCPA negotiations for Perjeta in combination with trastuzumab and chemotherapy for eligible patients with HER2-positive early-stage breast cancer, bringing the treatment closer to potential public reimbursement across Canada.
Pan-Canadian Pharmaceutical Alliance | 20/08/2026 | By News Bureau
Cipher Pharmaceuticals Secures pCPA Agreement to Expand Public Access to Epuris Across Canada
Cipher Pharmaceuticals has completed negotiations with the pan-Canadian Pharmaceutical Alliance, securing a Letter of Intent for Epuris (isotretinoin). The agreement represents a significant step toward expanding public drug plan coverage and improving patient access to severe acne treatment across Canada.
Pan-Canadian Pharmaceutical Alliance | 09/07/2026 | By News Bureau | 112
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy